Format

Send to

Choose Destination
Mayo Clin Proc. 2017 Oct;92(10):1583-1591. doi: 10.1016/j.mayocp.2017.08.002.

Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer.

Author information

1
Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ; Mayo Clinic Comprehensive Cancer Center, Scottsdale, AZ; Department of Molecular Medicine, Mayo Clinic, Rochester, MN; Center for Individualized Medicine, Mayo Clinic, Rochester, MN. Electronic address: borad.mitesh@mayo.edu.
2
Yale Cancer Center, Yale School of Medicine, New Haven, CT.

Abstract

The advent of next-generation sequencing has accelerated the implementation of genomic profiling in the care and management of patients with cancer. Initial efforts have focused on target identification in patients with advanced cancer. Prognostication, resistance detection, disease monitoring, and early detection efforts are also underway. This review highlights some of the challenges in this evolving space. This includes choosing between gene-panel and comprehensive approaches, DNA and transcriptome data integration, reduction of false-positive variants, addressing tumor heterogeneity, establishment of workflows to address unsolicited findings, and data sharing and privacy concerns.

PMID:
28982488
DOI:
10.1016/j.mayocp.2017.08.002
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center